| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |